ArticleResuscitation plus2026
First automated detection of a cardiac arrest using a commercially available smartwatch: a case report.
Article in Resuscitation plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Automated cardiac arrest detection aims to shorten the time between arrest onset and emergency medical services activation, thereby reducing the number of unwitnessed out-of-hospital cardiac arrests (OHCA) and shortening time to treatment in witnessed OHCA. Current arrest detection algorithms are largely developed using simulated or artificially induced cardiac arrest data. To our knowledge, this case report provides the first detailed description of the automated detection of spontaneous, non-procedural, end-of-life cardiac arrest using consumer-grade smartwatch-derived sensor data. Case report: An 82-year-old patient presented to the emergency department with a severe intracerebral hemorrhage with poor prognosis. Following shared decision-making with the family, palliative management was initiated. The patient was continuously monitored with electrocardiography (ECG), invasive arterial blood pressure, and clinical photoplethysmography (PPG). In addition, a commercial smartwatch was placed on the wrist to collect sensor data during the palliative phase and up to 20 min after confirmed cardiac arrest. The smartwatch PPG data were retrospectively analyzed using a previously described diagnostic algorithm. This preliminary algorithm detects circulatory arrest using the photoplethysmography sensor signals acquired from a commercial smartwatch. The algorithm accurately identified the moment of cardiac arrest in concordance with the clinical reference signals. Informed consent was obtained for this research from a legal representative. Conclusion: Although this controlled end-of-life setting does not represent the circumstances of an OHCA, this case demonstrates the feasibility of detecting true cardiac arrest using a commercial available smartwatch. Prospective studies in real-world OHCA populations are needed to assess clinical performance and practical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.